Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

UCSF grants uniQure rights to GDNF data for use with Parkinson’s gene therapy

Executive Summary

The University of California, San Francisco, has licensed newly formed gene therapeutics start-up uniQure BV exclusive rights to preclinical and IND-enabling data generated by a therapy encoding the glial cell-derived neurotrophic factor (GDNF) gene for Parkinson’s disease. The company will also have access to clinical data.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • R&D and Marketing (Licensing)

Related Companies